Suswapna Singh Rawat: The Role of Platelets in Heart Disease and Antiplatelet Therapy
Suswapna Singh Rawat, Physician, shared a post on LinkedIn:
“Platelets play a crucial role in managing ruptures within blood vessels and contributing to blockages in smaller vessels.
While they are essential for clotting, in cases of established heart disease, stents, or bypasses, reducing their activity becomes vital.
Antiplatelet medications like aspirin, clopidogrel, dipyridamole, and ticagrelor are instrumental in these scenarios.
They work by making blood less prone to clotting and aggregation, thereby easing passage through blockages.
For individuals without existing heart conditions, platelets have a less pronounced role, but for those with diagnosed heart disease or recent interventions, these medications are critical.
Management of heart disease is multifactorial, involving measures to reduce blood pressure, inflammation, and LDL cholesterol, alongside controlling platelet activity.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 25, 2026, 19:55Giacomo Buso: LIPLEG Provides the Strongest Evidence to Date on Lipedema Treatment
-
Oct 25, 2026, 19:54Nicholas Lee: ASH Program Connects Trainees and Faculty With Mentors for Career Development
-
Oct 25, 2026, 19:53World Thrombosis Day Raises Blood Clot Awareness at Italian Airports
-
Oct 25, 2026, 19:49Tahsim Anwar: A Six-Year Analysis of Adverse Events in Therapeutic Apheresis
-
Oct 25, 2026, 19:37William Wallace: More than 1 in 3 People with Parkinson’s Were Low in B6
-
Oct 25, 2026, 19:36Andrés Felipe Escobar González: Individualized Treatment Strategies for HMB in BDUC
-
Oct 25, 2026, 19:34Christophe Nougier: Returning to Burundi for the WFH-Supported Twinning Project
-
Oct 25, 2026, 19:29Bogda Koczwara: Pre-Existing and New CVD in Patients With Cancer Are Associated With Higher Mortality
-
Oct 25, 2026, 19:23Özlem Turan: Advancing Care for Women and Girls With Bleeding Disorders at the European Parliament